Related Experiment Video
Updated: Aug 19, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Prevention of drug access to bacterial targets: permeability barriers and active efflux
1Department of Molecular and Cell Biology, University of California, Berkeley 94720-3206.
Abstract:
Some species of bacteria have low-permeability membrane barriers and are thereby "intrinsically" resistant to many antibiotics; they are selected out in the multitude of antibiotics present in the hospital environment and thus cause many hospital-acquired infections. Some strains of originally antibiotic-susceptible species may also acquire resistance through decreases in the permeability of membrane barriers. Another mechanism for preventing access of drugs to targets is the membrane-associated energy-driven efflux, which plays a major role in drug resistance, especially in combination with the permeation barrier. Recent results indicate the existence of bacterial efflux systems of extremely broad substrate specificity, in many ways reminiscent of the multidrug resistance pump of mammalian cells. One such system seems to play a major role in the intrinsic resistance of Pseudomonas aeruginosa, a common opportunistic pathogen. As the pharmaceutical industry succeeds in producing agents that can overcome specific mechanisms of bacterial resistance, less specific resistance mechanisms such as permeability barriers and multidrug active efflux may become increasingly significant in the clinical setting.
Insights
Intrinsically antibiotic-resistant bacteria, with low-permeability membranes and efflux pumps, cause hospital infections. These non-specific resistance mechanisms are increasingly important as specific drug resistance is overcome.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Bacterial intrinsic antibiotic resistance is a significant challenge in healthcare settings.
- Low-permeability membrane barriers and energy-driven efflux pumps are key mechanisms conferring resistance.
- Hospital-acquired infections are often caused by intrinsically resistant bacteria.
Purpose of the Study:
- To investigate the role of membrane permeability and efflux systems in bacterial antibiotic resistance.
- To highlight the increasing clinical significance of non-specific resistance mechanisms.
Main Methods:
- Analysis of bacterial membrane properties and their impact on antibiotic susceptibility.
- Investigation of energy-dependent efflux systems and their substrate specificity.
- Case study focusing on Pseudomonas aeruginosa as a model opportunistic pathogen.
Main Results:
- Low-permeability membranes confer intrinsic resistance to various antibiotics.
- Broad-substrate efflux systems, similar to mammalian multidrug resistance pumps, are crucial for resistance.
- Pseudomonas aeruginosa utilizes such systems for intrinsic resistance.
Conclusions:
- Non-specific resistance mechanisms, including permeability barriers and multidrug efflux, are critical in the clinical setting.
- As specific antibiotic resistance is addressed, these less specific mechanisms will become more prominent.
- Understanding these pathways is vital for developing new strategies against hospital-acquired infections.
More Related Videos
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Bioavailability Enhancement: Drug Permeability Enhancement
Development of Antibiotic Resistance

